Apollo Commercial Real Estate Finance (ARI)
(Real Time Quote from BATS)
$10.17 USD
-0.13 (-1.26%)
Updated Sep 9, 2024 10:10 AM ET
5-Strong Sell of 5 5
D Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Apollo Commercial Real Estate Finance falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 345 | 304 | 285 | 279 | 334 |
Cost Of Goods | 38 | 38 | 38 | 40 | 41 |
Gross Profit | 307 | 265 | 246 | 239 | 294 |
Selling & Adminstrative & Depr. & Amort Expenses | 111 | 83 | 51 | 27 | 24 |
Income After Depreciation & Amortization | 196 | 182 | 195 | 212 | 270 |
Non-Operating Income | -138 | 83 | 29 | -194 | -39 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 59 | 265 | 224 | 18 | 230 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 58 | 265 | 224 | 18 | 230 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 58 | 265 | 224 | 18 | 230 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 189 | 144 | 142 | 163 | 200 |
Depreciation & Amortization (Cash Flow) | -7 | -38 | -53 | -49 | -70 |
Income After Depreciation & Amortization | 196 | 182 | 195 | 212 | 270 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 141.28 | 165.51 | 168.40 | 148.00 | 175.80 |
Diluted EPS Before Non-Recurring Items | 0.94 | 1.52 | 1.23 | 1.40 | 1.77 |
Diluted Net EPS (GAAP) | 0.29 | 1.68 | 1.46 | 0.01 | 1.40 |
Fiscal Year end for Apollo Commercial Real Estate Finance falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 81.11 | 80.54 | 84.15 | 81.16 | 92.16 |
Cost Of Goods | 9.17 | 9.42 | 9.55 | 9.52 | 9.39 |
Gross Profit | 71.94 | 71.11 | 74.60 | 71.64 | 82.77 |
SG&A, R&D, and Dept/Amort Expenses | 31.55 | 31.93 | 28.25 | 27.63 | 29.63 |
Income After SG&A, R&D, and Dept/Amort Expenses | 40.39 | 39.18 | 46.35 | 44.01 | 53.14 |
Non-Operating Income | -4.51 | -143.60 | 0.12 | 2.58 | -136.54 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 35.89 | -104.41 | 46.47 | 46.59 | -83.40 |
Income Taxes | 0.10 | 0.11 | -0.08 | 0.52 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 35.79 | -104.52 | 46.54 | 46.07 | -83.40 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 35.79 | -104.52 | 46.54 | 46.07 | -83.40 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 140.61 | 141.87 | 141.36 | 141.35 | 141.34 |
Diluted EPS Before Non-Recurring Items | 0.32 | 0.32 | 0.31 | 0.34 | -0.14 |
Diluted Net EPS (GAAP) | 0.23 | -0.76 | 0.29 | 0.30 | -0.62 |